J.C. Scott Archives - CDR – Chain Drug Review

PCMA makes statement on congressional committee hearings on drug prices

March 7, 2019 by Chain Drug Review J.C. Scott, Pharmaceutical Care Management Association (PCMA), prescription drug pricing issues Leading Headlines, Pharmacy

(Washington, D.C.) — As several congressional committees today examine prescription drug pricing issues Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement: “We applaud the Senate Aging Committee, the House Ways and Means Subcommittee on Health, and the House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law for holding today’s

PCMA issues statement on prescription drug rebate legislation

March 6, 2019 by Chain Drug Review J.C. Scott, PCMA, The Drug Price Transparency Act Leading Headlines, Pharmacy

WASHINGTON — Pharmaceutical Care Management president and chief executive officer J.C. Scott issued the following statement on newly introduced legislation by Senator Mike Braun (R, Ind.), “The Drug Price Transparency Act:” “We stand ready to work with Senator Braun and other policymakers who share the goal of reducing high drug costs. Pharmacy benefit managers (PBMs) are the

PCMA launches new advertising campaign

February 25, 2019 by Chain Drug Review J.C. Scott, Pharmaceutical Care Management Association (PCMA) Leading Headlines, Pharmacy

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers (PBMs) negotiate from drugmakers, and warn against the Administration’s newly proposed regulation that would eliminate these savings for beneficiaries and significantly increases costs to taxpayers. Click

PCMA comments on administration’s prescription drug rebate proposed rule

February 1, 2019 by Chain Drug Review Health and Human Services Office of Inspector General's proposed rule on prescription drug rebates in Medicare:, J.C. Scott, Pharmaceutical Care Management Association (PCMA) Leading Headlines, Pharmacy

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott issued the following statement on the Health and Human Services Office of Inspector General’s proposed rule on prescription drug rebates in Medicare: “While we are reviewing the proposed rule, we stand ready to work with the Administration to achieve our shared goal

PCMA issues statement on proposal requiring list prices of drugs in TV ads

October 16, 2018 by Chain Drug Review Department of Health and Human Services, drug companies to disclose the list price of prescription drugs in television ads, J.C. Scott, Pharmaceutical Care Management Association (PCMA) Leading Headlines, Pharmacy

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement on the Department of Health and Human Services’ proposal requiring drug companies to disclose the list price of prescription drugs in television ads: “We share the Administration’s goal of reducing prescription drug prices. Pharmacy benefit managers (PBMs) foster competition among drugmakers, resulting